What This Means
This research suggests that Enhydrin, a natural compound found in yacon (an Andean root vegetable), may help slow the development of atherosclerosis — the buildup of fatty plaques in blood vessel walls that underlies heart attacks and strokes. The researchers used a combination of computer-based analysis (including machine learning and analysis of gene activity in individual cells) to identify a protein called FABP5 as a key molecular target involved in both atherosclerosis and the effects of yacon's active ingredients. They then confirmed computationally that Enhydrin binds strongly to FABP5, and tested its effects in mice prone to atherosclerosis fed a high-fat diet.
In the animal experiments, mice treated with Enhydrin showed lower levels of harmful blood fats (triglycerides, total cholesterol, and LDL cholesterol), higher levels of protective HDL cholesterol, less fat buildup in the liver, and reduced fatty plaque formation in their arteries. At the molecular level, Enhydrin reduced the activity of FABP5, which is involved in transporting fatty acids inside cells, and increased the activity of two other proteins — PPARγ and ABCA1 — that help move cholesterol out of cells, a process called cholesterol efflux. Together, these changes suggest Enhydrin works through a specific biological pathway (FABP5/PPARγ/ABCA1) to improve fat metabolism and reduce arterial plaque buildup.
This research suggests that Enhydrin from yacon could be a candidate for further development as a treatment for atherosclerosis, and that FABP5 may be a useful drug target. However, these findings are based on animal and computational studies, and further research — including clinical trials in humans — would be needed before any clinical applications could be established.